Can You Donate Plasma on GLP-1 Medications? What Each Major Donor Center Actually Allows in 2026

Direct answer (40-60 words)

Yes, in most cases. The American Red Cross, Vitalant, CSL Plasma, BioLife, and Grifols Biomat USA do not list semaglutide, tirzepatide, or liraglutide as automatic deferrals. Eligibility comes down to the underlying condition (diabetes vs. obesity), how stable you are on the medication, and your hemoglobin and blood pressure on the day of donation.

Table of contents

1. The 30-second answer
2. Why people ask this question more in 2026 than ever before
3. How donor centers actually decide eligibility
4. Center-by-center rules: Red Cross, Vitalant, CSL, BioLife, Grifols
5. Diabetes vs. weight management: why the indication matters
6. The 8-week stability rule and where it comes from
7. What to disclose on the Donor Health Questionnaire
8. Hemoglobin, blood pressure, and weight thresholds
9. Side effects that will defer you on the day of donation
10. Whole blood donation vs. plasma donation: the differences
11. Compounded GLP-1s and donor center disclosure
12. FAQ

Why people ask this question more in 2026 than ever before

GLP-1 prescribing in the United States has roughly tripled since 2022. By the most recent National Health Interview Survey data, about 1 in 8 American adults has tried a GLP-1 medication for diabetes or weight management. That same population overlaps heavily with regular plasma donors. A typical paid plasma donor is 25 to 55 years old, with a healthy BMI, and often an active interest in personal health and supplemental income. Many of those people are now on weekly semaglutide or tirzepatide.

The donor centers have noticed. CSL, BioLife, and Grifols all updated their internal medication lists in 2023 and again in 2024 to address GLP-1 medications specifically. The Red Cross issued a one-paragraph clarification in late 2023 stating that GLP-1 receptor agonists are not on its medication deferral list. Vitalant did the same.

So the answer to "can I donate plasma on Ozempic" is generally yes, but the practical answer depends on which center you walk into and what's on your screening form.

How donor centers actually decide eligibility

Plasma donation centers run two parallel checks at every visit. Both have to pass for you to donate.

Check 1: The medication deferral list. Each center maintains a list of medications that automatically defer you. The list focuses on medications that pose a transfusion risk to the recipient or a safety risk to the donor during the procedure. Common examples include warfarin, certain acne medications (Accutane), some psoriasis treatments, growth hormone, and a handful of immunosuppressants. GLP-1 medications are not on any major U.S. donor center's automatic deferral list as of Q1 2026.

Check 2: The Donor Health Questionnaire (DHQ) plus the on-site physical. Even if your medication is allowed, the underlying condition might not be. Uncontrolled diabetes, recent hospitalization, active infection, low hemoglobin, abnormal blood pressure or pulse, or recent illness will defer you on the day. The screening nurse or paramedic makes this judgment based on your answers and your physical assessment.

For GLP-1 patients, both checks are usually fine. The medication is allowed, and the underlying condition (well-managed type 2 diabetes or obesity) is not disqualifying. What trips people up is the on-site physical. If you're 4 weeks into starting Mounjaro and your blood pressure is low because you're nauseated and underhydrated, you'll get deferred for the day.

Center-by-center rules: Red Cross, Vitalant, CSL, BioLife, Grifols

The five organizations below cover the vast majority of U.S. plasma collection. Their rules in 2026 are summarized in the table.

Donor center	GLP-1s on deferral list?	Diabetes restrictions	Notes
American Red Cross	No	Type 2 diabetes acceptable if stable; insulin-treated diabetes acceptable if stable for 28+ days	Whole blood and plasma; not a paid donor program
Vitalant	No	Type 2 acceptable if controlled; type 1 with insulin acceptable	Mostly whole blood; some plasma centers
CSL Plasma	No	Type 2 acceptable if controlled; insulin users may have additional questions	Largest paid plasma network; focus on source plasma for therapeutic products
BioLife (Takeda)	No	Type 2 acceptable; type 1 may face additional review	Paid donor program; weekly visit limits
Grifols (Biomat USA)	No	Type 2 acceptable; insulin OK with stability	Paid donor program; multiple branded centers

The "stable" language is consistent across centers and matters in practice. Stable usually means no medication change in the past 14 to 28 days, no recent hypoglycemia or hyperglycemia events, and no recent hospitalization for diabetes-related issues.

GLP-1 patients without diabetes (taking semaglutide or tirzepatide off-label or for obesity) face fewer questions on average. The screener may not even ask about the indication, just about the medication name.

Diabetes vs. weight management: why the indication matters

The indication on your prescription influences what the screener asks and how cautious the deferral decision is.

If you're taking Ozempic or Mounjaro for type 2 diabetes, the screener will probably ask:

• When were you diagnosed?
• What's your current A1C?
• Have you been hospitalized for diabetes in the past 12 months?
• Are you also on insulin? If so, has the dose changed in the past 28 days?
• Have you had a hypoglycemic episode requiring assistance in the past 28 days?

If your answers are reassuring, you donate. If they aren't, you get deferred.

If you're taking Wegovy, Zepbound, or compounded semaglutide/tirzepatide for weight management, the questions are usually shorter:

• What medication and dose?
• When did you start?
• Have you had any side effects in the past week?

The reason the questions are shorter for weight-management patients is that the underlying condition (obesity) doesn't directly affect plasma quality or the donor's safety during the procedure the way uncontrolled diabetes can. The Red Cross specifically notes that obesity is not a disqualifying condition.

What matters in both cases is whether your medication has been stable. A patient who started Wegovy yesterday and is feeling nauseated will probably be deferred for the day. A patient who has been on Wegovy 1.7 mg for 6 months and feels fine will donate without issue.

The 8-week stability rule and where it comes from

Several centers (notably CSL and BioLife) apply a soft "8-week stability" rule for new medications. The rule isn't a hard deferral; it's a screening filter that flags patients for additional questions.

The rationale: in the first 4 to 8 weeks of a new GLP-1, side effects (nausea, vomiting, dehydration, fatigue) are most common. Donating plasma when you're already volume-depleted from GI side effects can drop your blood pressure and cause syncope (fainting) during or after donation. Centers want to protect donors from a bad experience, not just protect recipients.

In practice, if you started Ozempic last week, you can probably still donate, but expect more questions. If your blood pressure on the day is borderline (under 110/70 for example) and you're newly on a GLP-1, the screener may defer you out of caution.

After 8 weeks at a stable dose, almost no center will ask follow-up questions about the medication. The exception is the day-of physical: if your blood pressure is low or your hemoglobin is low, you get deferred regardless of how long you've been on the medication.

What to disclose on the Donor Health Questionnaire

The DHQ is a standardized form used at every U.S. donor center. Most centers use the AABB Uniform Donor History Questionnaire as the base, with center-specific additions.

The medication-related questions you'll see:

1. "In the past 4 weeks, have you taken any medications or pills?" Yes. List your GLP-1.
2. "Have you started any new medications in the past 28 days?" Yes if applicable.
3. "Have you had any changes to dose or frequency of medications you take regularly?" Yes if applicable (any titration step counts).
4. "Are you currently feeling well and healthy?" Be honest. If you're nauseated, say so.
5. Specific medication-list questions. Some centers list specific medications by name. GLP-1s are not on the deferral lists. If the screener pulls up a list and your medication isn't on it, you're cleared on the medication question.

What not to do: don't omit the medication. Donor centers ask the question for safety reasons, and lying on a federal medical questionnaire can get you permanently deferred and (in rare cases) prosecuted. The accurate answer almost always lets you donate. Hiding the medication only creates risk.

If you're on compounded semaglutide or tirzepatide, write the medication name and the compounding pharmacy. Most screeners will treat compounded GLP-1s the same as brand-name versions for donor eligibility purposes. If they're unfamiliar, the medical director can verify.

Hemoglobin, blood pressure, and weight thresholds

GLP-1 patients face the same physical screening thresholds as everyone else, but a few thresholds are more likely to be borderline because of how the medications affect appetite and hydration.

Hemoglobin minimums:

• Whole blood donation: 12.5 g/dL (women) or 13.0 g/dL (men)
• Plasma donation (most paid centers): 11.0 g/dL minimum

GLP-1s don't directly cause anemia, but reduced food intake plus underlying iron deficiency can drop hemoglobin in some patients. If you're a regular donor and your hemoglobin is trending down, an iron panel from your primary care provider is worth getting.

Blood pressure ranges:

• Most centers: 90/50 to 180/100 acceptable
• Outside the range: same-day deferral

GLP-1 patients sometimes run on the low end of the range, especially during titration when nausea reduces fluid intake. If your typical reading is 100/60, drink 16 to 20 ounces of water in the hour before your appointment to avoid borderline readings.

Weight minimums:

• Plasma donation: 110 lb (50 kg) minimum at most centers
• Whole blood donation: 110 lb minimum

For patients who have lost significant weight on a GLP-1, this rarely matters in practice (110 lb is below most adult weight ranges) but is worth mentioning. A thin patient who has lost 60 lb on Wegovy and is now at 115 lb will pass the weight check but should make sure to eat adequately before donation.

Pulse:

• 50 to 100 bpm acceptable at most centers
• Athletic donors with a resting pulse below 50 may need a note from a provider

Side effects that will defer you on the day of donation

Even though GLP-1s are not on the deferral list, the side effects can defer you on the day. Watch for:

• Active nausea or vomiting. Same-day deferral. The donation itself can worsen nausea, and dehydration from vomiting raises syncope risk.
• Diarrhea within the past 24 hours. Most centers defer for 24 to 48 hours after diarrhea resolves.
• Dizziness or lightheadedness. Same-day deferral. Often related to dehydration on a GLP-1.
• Recent dose escalation (within 7 to 14 days). Soft flag at most centers; hard deferral at some.
• Active gallstone or pancreatitis symptoms. Hard deferral until evaluated by a clinician. Both are recognized GLP-1 risks.
• Heart rate over 100 bpm. GLP-1s have a small effect on heart rate (typically a 2 to 4 bpm increase). If your resting rate is already on the high end, you may exceed the threshold.

A simple rule: if you'd rather not be at the donor center, your body is telling you to reschedule. Donor centers don't reward toughness; they protect donors and recipients by deferring anyone who isn't fully well on the day.

Whole blood donation vs. plasma donation: the differences

The eligibility rules are similar but not identical between whole blood and plasma.

Whole blood donation (Red Cross, hospital blood drives):

• One donation every 56 days (8 weeks) for whole blood
• Hemoglobin minimum 12.5 to 13.0 g/dL
• Volume taken: about 500 mL
• Same medication rules as plasma; GLP-1s allowed

Plasma donation (CSL, BioLife, Grifols):

• Up to twice per week (with at least 48 hours between donations)
• Hemoglobin minimum 11.0 g/dL (lower because RBCs are returned)
• Volume taken: about 690 to 880 mL of plasma per session, depending on weight
• Plasmapheresis machine separates plasma and returns RBCs and platelets
• Same medication rules as whole blood; GLP-1s allowed

Plasma donation is more frequent, which means GLP-1 patients on stable doses can establish a routine without cumulative effects. Whole blood donation's longer interval (56 days) means side effects from GLP-1 titration are unlikely to coincide with donation visits.

Compounded GLP-1s and donor center disclosure

Compounded semaglutide and tirzepatide are increasingly common. Donor center screeners are usually familiar with brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) but may pause when they hear "compounded semaglutide from a pharmacy."

What to do:

• Write the active ingredient (semaglutide or tirzepatide) on the form
• Note that it's compounded by a state-licensed pharmacy
• Bring a label or prescription if asked
• Don't avoid disclosure to skip the question

The active ingredient is the same molecule as the brand-name product, so the medical evaluation is the same. The compounding status doesn't change donor eligibility. Some screeners will call the medical director for confirmation; this is normal and not a sign of trouble.

If you're using compounded medication from FormBlends, you can find the medication name and concentration on the vial label and the prescription record in your account. Bring or photograph either if you anticipate questions.

For more on what FormBlends compounded products contain, see related guide and related guide.

FAQ

Can I donate plasma on Ozempic?

Yes. Ozempic (semaglutide) is not on the deferral list at any major U.S. plasma donor center as of 2026. You'll need to disclose the medication on your Donor Health Questionnaire and pass the on-site physical screening, but the medication itself is allowed.

Can I donate plasma on Wegovy?

Yes. Wegovy contains semaglutide and is treated the same as Ozempic for donor eligibility purposes. The indication (weight management vs. diabetes) doesn't change donor eligibility.

Can I donate plasma on Mounjaro or Zepbound?

Yes. Tirzepatide is not on any major U.S. donor center's deferral list. Disclose the medication and pass the day-of physical, and you can donate.

Do I need to wait a certain time after starting a GLP-1 before donating?

No formal waiting period exists at most centers. Some centers apply a soft 4 to 8 week stability rule, meaning newer patients may face additional questions. If you're tolerating the medication well and your vitals are normal, you can usually donate.

What if I had nausea this morning?

Reschedule. Active GI symptoms are a same-day deferral at every donor center. You can donate as soon as the symptoms resolve, usually within 24 to 48 hours.

Will my GLP-1 medication show up in the donated plasma?

Trace amounts of semaglutide or tirzepatide may be present in donor plasma, but the levels are far below any therapeutic threshold for the recipient. Plasma is processed into therapeutic protein products (immunoglobulin, clotting factors, albumin) that don't include intact GLP-1 molecules.

Does compounded semaglutide change my eligibility?

No. The active ingredient is the same as the brand-name version. Disclose the medication, including the fact that it's compounded, and the screener will treat it the same as the brand-name version.

What hemoglobin level do I need for plasma donation on a GLP-1?

The standard 11.0 g/dL minimum applies. GLP-1s don't directly cause anemia, but reduced food intake during dose titration can lower iron stores in some patients. If your hemoglobin trends down, get an iron panel from your primary care provider.

Can I donate the same day I take my weekly GLP-1 injection?

Yes, if you're feeling well. There's no rule against same-day donation. Many patients prefer to donate a day or two before injection day, when they're past peak side effects from the prior week's dose.

What if I'm on insulin plus a GLP-1?

Most centers allow it if the regimen has been stable for 28 days. Insulin-treated diabetes is acceptable at all major U.S. centers, but new insulin starts trigger a 28-day deferral.

Will the screener know what semaglutide is?

Most will. Donor center medical staff are trained on common medications and have ongoing updates. If a screener is unsure, they consult the center's medical director, who has up-to-date information.

Can I donate plasma if I've recently lost a lot of weight on a GLP-1?

Yes, as long as you're above the 110 lb minimum, your hemoglobin is adequate, and you're feeling well. Significant recent weight loss isn't a disqualifying factor by itself.

What documentation should I bring?

Your insurance card or ID, a list of current medications with doses and frequencies, and (if asked) the prescription label or vial for compounded medications. Most centers don't require documentation for self-reported medications.

Author / review note

Reviewed by the FormBlends Medical Team. References include the AABB Uniform Donor History Questionnaire (current version), Red Cross eligibility guidelines (2024 update), CSL Plasma medication policy, BioLife Plasma Services donor guidelines, and the FDA guidance on plasma collection from donors with type 2 diabetes.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. American Red Cross, Vitalant, CSL Plasma, BioLife, and Grifols are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.